Intra-arterial infusion of chemotherapy for advanced hepatocellular carcinoma: An Asian perspective


  • Stephen L. CHAN,

    1. State Key Laboratory in Oncology in South China, Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Prince of Wales Hospital, the Chinese University of Hong Kong, Hong Kong
    Search for more papers by this author
  • Philip JOHNSON

    1. Cancer Research UK Institute for Cancer Studies, University of Birmingham, School of Cancer Sciences, Birmingham, UK
    Search for more papers by this author

  • Disclosures: Dr Stephen L. Chan has served as an advisor for Astra-Zeneca, Novartis and Pfizer. No related disclosures for Professor Philip Johnson